Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02249377 · ClinicalTrials.gov registry record · Phase 3
PRP vs Corticosteroid in Baker's Cyst
A Phase 3 study, sponsored by NYU Langone Health.
- Terminated
- Registry status
- Phase 3
- Development phase
- 50
- Enrollment target
NCT02249377 is a Phase 3 study that was terminated before completion, run by NYU Langone Health. The registered enrollment target is 50 participants.
The verdict
NCT02249377, a Phase 3 study, was terminated before completion, sponsored by NYU Langone Health.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 50 participants
- Enrollment target
Study Summary
This is a Prospective study with Randomized patients into either Ultrasound-guided Platelets-Rich-Plasma injection and Ultrasound guided Corticosteroid Injection, with 3 months and 6 months follow ups after aspiration at our institution. There will be 25 patients in each group, including any patient with symptomatic baker's cyst.
Interventions
- DRUG Corticosteroid
- OTHER Platelets-Rich-Plasma
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2014-02 |
| Est. Completion | 2017-04-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02249377
The ClinicalTrials.gov registry entry for NCT02249377 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Corticosteroid is the first listed.
NCT02249377 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02249377 about?
NCT02249377 is a clinical study titled "PRP vs Corticosteroid in Baker's Cyst". This is a Prospective study with Randomized patients into either Ultrasound-guided Platelets-Rich-Plasma injection and Ultrasound guided Corticosteroid Injection, with 3 months and 6 months follow ups after aspiration at our institution. There will be 25 patients in each group, including any patient...
What is the current status of trial NCT02249377?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 50 participants. The study started on 2014-02. Estimated completion is 2017-04-01.
What interventions are being tested in trial NCT02249377?
The interventions under investigation include: Corticosteroid (DRUG), Platelets-Rich-Plasma (OTHER).
Who is sponsoring clinical trial NCT02249377?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.